TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,296
|
4,632
|
2,103 |
Financial expenses |
7
|
1
|
0 |
Earnings before taxes |
99
|
-2
|
102 |
EBITDA |
120
|
17
|
117 |
Total assets |
6,707
|
2,372
|
700 |
Current assets |
6,698
|
2,350
|
678 |
Current liabilities |
6,439
|
2,205
|
516 |
Equity capital |
268
|
168
|
185 |
- share capital |
34
|
33
|
36 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.0%
|
7.1%
|
26.4% |
Turnover per employee |
1,074
|
1,158
|
701 |
Profit as a percentage of turnover |
2.3%
|
0.0%
|
4.9% |
Return on assets (ROA) |
1.6%
|
0.0%
|
14.6% |
Current ratio |
104.0%
|
106.6%
|
131.4% |
Return on equity (ROE) |
36.9%
|
-1.2%
|
55.1% |
Change turnover |
-359
|
2,699
|
441 |
Change turnover % |
-8%
|
140%
|
27% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
33%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.